Follow
Paula Cebollada Rica
Paula Cebollada Rica
Verified email at upf.edu
Title
Cited by
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
13164*2021
Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2
A Barreiro, A Prenafeta, G Bech-Sabat, M Roca, EP Mur, R March, ...
Iscience 26 (3), 2023
72023
Functional cure of a chronic virus infection by shifting the virus-host equilibrium state
GA Bocharov, D Grebennikov, P Cebollada Rica, E Domenjó Vila, ...
Front Immunol. 2022 Aug 30; 13: 904342, 2022
52022
Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate
A Moros, A Prenafeta, A Barreiro, E Perozo, A Fernández, M Cañete, ...
Vaccine 41 (35), 5072-5078, 2023
32023
Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates
A Prenafeta, G Bech-Sàbat, A Moros, A Barreiro, A Fernández, M Cañete, ...
Iscience 26 (7), 2023
22023
XCR1+ DCs are critical for T cell-mediated immunotherapy of chronic viral infections
E Domenjo-Vila, V Casella, R Iwabuchi, E Fossum, M Pedragosa, ...
Cell Reports 42 (2), 2023
12023
Differential kinetics of splenic CD169+ macrophage death is one underlying cause of virus infection fate regulation
V Casella, E Domenjo-Vila, A Esteve-Codina, M Pedragosa, ...
Cell Death & Disease 14 (12), 838, 2023
2023
Mathematical Model Predicting the Kinetics of Intracellular LCMV Replication
J Sergeeva, D Grebennikov, V Casella, P Cebollada Rica, A Meyerhans, ...
Mathematics 11 (21), 4454, 2023
2023
Preclinical efficacy, safety, and immunogenicity of PHH-1V, a second-generation COVID-19 vaccine, in non-human primates
A Prenafeta, G Bech-Sàbat, S Moros, A Barreiro, A Fernández, M Cañete, ...
bioRxiv, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–9